Psychedelics for Mental Health: Help or Hype?

Magic mushrooms, MDMA, and Ketamine. These psychedelic drugs, once a taboo, might not be as harmful as we thought. Some scientific studies have shown evidence that psychedelic drugs, when used in controlled therapeutic settings, may help patients with anxiety, PTSD, and depression. While states like Oregon have legalized psilocybin therapy, the FDA recently decided in a high-profile case not to approve MDMA therapy. Should doctors still consider its use, or is it overhyped? Those who advocate for psychedelic treatments argue it could be a welcome relief for patients who don’t respond to traditional medications and therapies and help fill a critical gap in the therapeutic landscape. However, those against recommending psychedelics are concerned about its risks, including the possibility of worsening certain mental health conditions, and we don’t yet understand the long-term effects of psychedelic use.
Now with this background, we debate the question: Psychedelics for Mental Health: Help or Hype?
Arguing Help: Ismail Ali, Director of Policy and Advocacy at MAPS
Arguing Hype: Kevin Sabet, President and CEO at the Foundation for Drug Policy Solutions
Emmy award-winning journalist John Donvan moderates
#opentodebate #debate #PsychedelicsDebate #MentalHealthDebate
#HelpOrHype #mushroom #fda #Psychedelics #MDMA #KetamineTherapy #Microdosing
#PsychedelicTherapy #DrugPolicy #MAPS #KevinSabet #IsmailAli #AlternativeMedicine
#psychedelicresearch
===================================
Subscribe: / @opentodebateorg
Official site: opentodebate.org/
Newsletter: opentodebate.o...
X: / opentodebateorg
Facebook: / beopentodebate
LinkedIn: / opentodebate
Instagram: / opentodebateorg
TikTok: / open.to.debate
Open to Debate Apple Podcasts: tinyurl.com/bd...
Open to Debate Spotify Podcasts: tinyurl.com/22...
===================================